Brucellosis clinical trials
The registry lists 50 studies for Brucellosis across more than 10 countries. 17 are recruiting or about to start. Per ClinicalTrials.gov, last updated 2026-08-21.
Status
- Completed
- 22
- Not yet recruiting
- 9
- Recruiting
- 7
- Status unknown
- 5
- Withdrawn
- 3
- Active, not recruiting
- 2
Phase
- Phase 2
- 9
- Phase 1
- 1
- Phase 4
- 1
Where
- Turkey
- 19
- Israel
- 7
- France
- 6
- United States
- 4
- Armenia
- 3
- Egypt
- 3
Who runs them
Istanbul University - Cerrahpasa (6) · Istanbul University (4) · Sheba Medical Center (3) · Novartis Pharmaceuticals (3) · Hospices Civils de Lyon (2) · University of Palermo (2) · R-Pharm International, LLC (2) · University Hospital, Montpellier (2)
Studies
Recruiting first, then most recently updated. Showing 50 of 50 — search for more.
- Efficacy & Safety of Fluoroquinolone-Based Brucellosis Regimens (BRUCE)Not yet recruitingNCT07779629Not applicable
- Risk Assessment of Community Spread of Multiple Endemic Infectious Diseases in a One Health PerspectiveRecruitingNCT073589101 country
- Can Gluten/Wheat or Other Foods be Responsible for FMF AttacksRecruitingNCT063388911 country
- Comparing Structured Neuromuscular Exercise and Exergaming Program in Adolescents With Familial Mediterranean FeverEnrolling by invitationNCT07013045Not applicable1 country
- Physical Activity in Adolescents With Familial Mediterranean FeverNot yet recruitingNCT069749421 country
- Serological Measurement of Montpellier Professionals' Contacts with Infectious Agents Responsible for Animal-borne DiseasesNot yet recruitingNCT06859619Not applicable1 country
- Investigation of the Validity, Reliability and Responsiveness of the BETY-BQ in FMFNot yet recruitingNCT068302131 country
- Comparison of the Effects of Synchronous and Asynchronous Telerehabilitation in Patients with Juvenile Familial Mediterranean FeverNot yet recruitingNCT06743152Not applicable1 country
- Safety and Efficacy of RPH-104 Used to Prevent Recurrent Fever Attacks in Adult Patients With Colchicine Resistant or Colchicine Intolerant Familial Mediterranean FeverRecruitingNCT05190991Phase 23 countries
- Barriers to Physical Activity in Familial Mediterranean FeverNot yet recruitingNCT067258491 country
- Gait Profile and Variables in Pediatric Rheumatic Disease Using a Smart Insole SystemNot yet recruitingNCT06705673
- Hematological Indices in Pediatric Diagnosed with Familial Mediterranean FeverNot yet recruitingNCT06583304
- Characterization of a Functional Test for Mediterranean Family Fever Screening - 2RecruitingNCT044784091 country
- Assessment of microRNAs Role in Familial Mediterranean Fever FMF PathophysiologyNot yet recruitingNCT06033339Not applicable1 country
- Evaluation of Bone Metabolism in Children and Adolescents With Familial Mediterranean FeverRecruitingNCT060347951 country
- The Effect of Video Game on Children With Familial Mediterranean FeverRecruitingNCT05980780Not applicable1 country
- Real World Study of Classic Infectious DiseaseRecruitingNCT040205361 country
- Seroprevalence of Brucella Antibodies in High-Risk Patients With Low Back Pain: A Case-Control StudyCompletedNCT071126771 country
- Assessment of Cardiorespiratory Fitness Using the PACER in Patients With Juvenile Idiopathic Arthritis and Familial Mediterranean FeverCompletedNCT066970281 country
- Evaluation of Familial Mediterranean Fever Impact on Oral and Dental Health in Children and AdolescentsCompletedNCT06934434Not applicable1 country
- A Study to Describe a Group of Spanish Patients With FMF and to Identify Suboptimally Treated Patients With Minimal Disease Activity and Its Impact on Quality of LifeCompletedNCT069231241 country
- Pilates Based Exercises in Patients With Behçet and Familial Mediterranean Fever.CompletedNCT04402255Not applicable1 country
- Familial Mediterranean Fever and Behçet: Analysis Before and After Covid19 PandemicCompletedNCT044034381 country
- Efficacy and Safety of RPH-104 for Resolution and Prevention of Recurring Attacks in Adult Subjects With Familial Mediterranean Fever With Resistance to or Intolerance of ColchicineActive, not recruitingNCT05092776Phase 24 countries
- Study of Colchicine Resistance in Familial Mediterranean FeverCompletedNCT05418686Not applicable1 country
- Heat Intolerance in the Group of FMF PatientsTerminatedNCT010592791 country
- Physical Abilities of Teenagers With Familial Mediterranean FeverActive, not recruitingNCT062573421 country
- A Multicentre, Retrospective Study of Clinical Characteristics and Long-term Outcomes of Patients With BrucellosisCompletedNCT060073261 country
- A Study to Evaluate RIST4721 in Familial Mediterranean Fever (FMF)WithdrawnNCT05448391Phase 2
- Central Sensitization in Familial Mediterranean Fever (FMF)CompletedNCT051771201 country
- Clinical and Molecular Evaluation of Childern With Familial Meditterranean Fever and Their SiblingsStatus unknownNCT05488561Not applicable1 country
- The Movement Imagery Ability in Patients With Familial Mediterranean FeverCompletedNCT047292181 country
- Investigation of Fever Suspected as a Zoonosis Using Advanced Diagnostic TechnologiesStatus unknownNCT047176221 country
- A Diagnostic Test for Familial Mediterranean FeverCompletedNCT037473151 country
- Brucella Serology and History of Brucellosis in Patients With Modic Changes Type 1CompletedNCT049112831 country
- Effects of Online Aerobic Exercise Training and Physical Activity Counseling in Juvenile Familial Mediterranean FeverStatus unknownNCT04724993Not applicable1 country
- Tocilizumab for the Treatment of Familial Mediterranean FeverCompletedNCT03446209Phase 21 country
- Cognitive Impairment and Neuropsychiatric Manifestations of NeurobrucellosisCompletedNCT043017521 country
- Gluten-related Disorders in Familial Mediterranean Fever PatientsCompletedNCT03563300Not applicable1 country
- Inflammatory Proteins in Familial Mediterranean Fever During Attack and RemissionWithdrawnNCT003234401 country
- Evaluate the Safety and Efficacy of Canakinumab in Pediatric Patients With Colchicine Intolerant or Colchicine Resistant Familial Mediterranean Fever (FMF)CompletedNCT01148797Phase 21 country
- Rapid Diagnostic Tests and Clinical/Laboratory Predictors of Tropical Diseases In Patients With Persistent Fever in Cambodia, Nepal, Democratic Republic of the Congo and Sudan (NIDIAG-Fever)CompletedNCT01766830Not applicable4 countries
- The Effect of Probiotics on Response to Therapy and on Adverse Effect in Patients Treated With Colchicine for Familial Mediterranean Fever.WithdrawnNCT02021084Not applicable
- The Comparison of the Efficacy of Once and Twice Daily Colchicine Dosage in Pediatric Patients With FMFCompletedNCT02602028Phase 41 country
- Controlled Ceasing of Colchicine Therapy in Familial Mediterranean Fever (FMF) Patients With Single MEFV (Mediterranean Fever) Gene MutationStatus unknownNCT02175589Phase 21 country
- Interleukin-1 Trap to Treat Autoinflammatory DiseasesCompletedNCT00094900Phase 21 country
- Rilonacept for Treatment of Familial Mediterranean Fever (FMF)CompletedNCT00582907Phase 21 country
- Efficacy and Safety of Canakinumab in Patients With Colchicine Resistant Familial Mediterranean FeverCompletedNCT01088880Phase 21 country
- Pharmacokinetics Study of Colchicine in Familial Mediterranean Fever (FMF) PatientsCompletedNCT01075906Phase 14 countries
- Magnetic Resonance (MR) Spectroscopy In Familial Mediterranean Fever (FMF) PatientsStatus unknownNCT006580601 country